Teljes publikációs lista
Publikációs időszak:
2015-2024
2024
Kovács, F.,
Balla, N.,
Bozó, A.,
Harmath, A.,
Jakab, Á.,
Tóth, Z.,
Nagy, F.,
Majoros, L.,
Kovács, R.:
Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, 2024.
Folyóirat-mutatók:
Q1 Dermatology (2023)
Q2 Infectious Diseases (2023)
Q1 Medicine (miscellaneous) (2023)
2023
Tóth, Z.,
Bozó, A.,
Kovács, R.,
Balogh, B.,
Balázs, B.,
Forgács, L.,
Kelentey, B.,
Majoros, L.:
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
Mycopathologia. 188 (1-2), 111-118, 2023.
Folyóirat-mutatók:
Q1 Agronomy and Crop Science
Q2 Applied Microbiology and Biotechnology
Q2 Microbiology
Q1 Plant Science
D1 Veterinary (miscellaneous)
Balla, N.,
Jakab, Á.,
Kovács, F.,
Ragyák, Á.,
Tóth, Z.,
Balázsi, D.,
Forgács, L.,
Bozó, A.,
Al Refai, F.,
Borman, A.,
Majoros, L.,
Kovács, R.:
Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol.
AMB Express. 13 (1), 1-10, 2023.
Folyóirat-mutatók:
Q2 Applied Microbiology and Biotechnology
Q2 Biophysics
2022
Balla, N.,
Kovács, F.,
Balázs, B.,
Borman, A.,
Bozó, A.,
Jakab, Á.,
Tóth, Z.,
Kobaissi, O.,
Majoros, L.,
Kovács, R.:
Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms.
Antibiotics-Basel. 11 (11), 1-12, 2022.
Folyóirat-mutatók:
Q2 Biochemistry
Q2 Infectious Diseases
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Pharmacology (medical)
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2020
Vitális, E.,
Nagy, F.,
Tóth, Z.,
Forgács, L.,
Bozó, A.,
Kardos, G.,
Majoros, L.,
Kovács, R.:
Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.
Folyóirat-mutatók:
Q1 Dermatology
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
2019
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Czeglédi, A.,
Rebenku, I.,
Majoros, L.,
Kovács, R.:
Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.
Folyóirat-mutatók:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Balázs, B.,
Majoros, L.:
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.
Folyóirat-mutatók:
Q2 Applied Microbiology and Biotechnology
2018
Nagy, F.,
Bozó, A.,
Tóth, Z.,
Daróczi, L.,
Majoros, L.,
Kovács, R.:
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Med. Mycol. 56 (4), 493-500, 2018.
Folyóirat-mutatók:
Q2 Infectious Diseases
Q1 Medicine (miscellaneous)
D1 Veterinary (miscellaneous)
Kardos, T.,
Kovács, R.,
Kardos, G.,
Varga, I.,
Bozó, A.,
Tóth, Z.,
Nagy, F.,
Majoros, L.:
Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.
Folyóirat-mutatók:
Q3 Infectious Diseases
Q2 Medicine (miscellaneous)
Q3 Oncology
Q3 Pharmacology
Q3 Pharmacology (medical)
Kovács, R.,
Nagy, F.,
Tóth, Z.,
Bozó, A.,
Majoros, L.:
The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 56 S131, 2018.
2017
Kovács, R.,
Tóth, Z.,
Nagy, F.,
Daróczi, L.,
Bozó, A.,
Majoros, L.:
Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
J. Appl. Microbiol. 122 (6), 1529-1536, 2017.
Folyóirat-mutatók:
Q2 Applied Microbiology and Biotechnology
Q2 Biotechnology
Q2 Medicine (miscellaneous)
Saleh, Q.,
Kovács, R.,
Kardos, G.,
Gesztelyi, R.,
Kardos, T.,
Bozó, A.,
Majoros, L.:
Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
Microb. Drug Resist. 23 (6), 764-770, 2017.
Folyóirat-mutatók:
Q3 Immunology
Q1 Medicine (miscellaneous)
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Pharmacology
Kovács, R.,
Saleh, Q.,
Bozó, A.,
Tóth, Z.,
Gesztelyi, R.,
Kardos, T.,
Kardos, G.,
Takács, I.,
Majoros, L.:
Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 182 (11-12), 979-987, 2017.
Folyóirat-mutatók:
Q2 Agronomy and Crop Science
Q2 Applied Microbiology and Biotechnology
Q3 Microbiology
Q2 Plant Science
Q2 Veterinary (miscellaneous)
Kardos, T.,
Saleh, Q.,
Kovács, R.,
Gesztelyi, R.,
Kardos, G.,
Bozó, A.,
Tóth, Z.,
Majoros, L.:
Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
New Microbiol. 40 (4), 286-288, 2017.
Folyóirat-mutatók:
Q2 Medicine (miscellaneous)
Q2 Microbiology (medical)
Kovács, R.,
Nagy, F.,
Bozó, A.,
Tóth, Z.,
Daróczi, L.,
Kardos, G.,
Majoros, L.:
The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
Acta Microbiol. Immunol. Hung. 62 152, 2017.
2016
Kovács, R.,
Bozó, A.,
Gesztelyi, R.,
Domán, M.,
Kardos, G.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.
Folyóirat-mutatók:
Q1 Infectious Diseases
D1 Medicine (miscellaneous)
Q1 Microbiology (medical)
D1 Pharmacology (medical)
Domán, M.,
Kovács, R.,
Kardos, G.,
Gesztelyi, R.,
Juhász, B.,
Bozó, A.,
Kardos, T.,
Saleh, Q.,
Majoros, L.:
Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.
Folyóirat-mutatók:
Q2 Pharmaceutical Science
Bozó, A.,
Domán, M.,
Majoros, L.,
Kardos, G.,
Varga, I.,
Kovács, R.:
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
J. Microbiol. 54 (11), 753-760, 2016.
Folyóirat-mutatók:
Q2 Applied Microbiology and Biotechnology
Q2 Medicine (miscellaneous)
Q3 Microbiology
Kovács, R.,
Bozó, A.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Acta Microbiol. Immunol. Hung. 64 16, 2016.
2015
Domán, M.,
Kovács, R.,
Perlin, D.,
Kardos, G.,
Gesztelyi, R.,
Juhász, B.,
Bozó, A.,
Majoros, L.:
Dose escalation studies with caspofungin against Candida glabrata.
J. Med. Microbiol. 64 (9), 998-1007, 2015.
Folyóirat-mutatók:
Q1 Medicine (miscellaneous)
Q2 Microbiology
Q2 Microbiology (medical)
Kovács, R.,
Bozó, A.,
Domán, M.,
Nagy, F.,
Tóth, Z.,
Majoros, L.:
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.
frissítve: 2024-09-01, 01:15
